HYDROmorphone in 0.9% sodium chloride, 10 mg/50 mL, (0.2 mg/mL), 50 mL Syringe, Rx only, Central ...

FDA Recall #D-0028-2024 — Class II — September 21, 2023

Recall #D-0028-2024 Date: September 21, 2023 Classification: Class II Status: Terminated

Product Description

HYDROmorphone in 0.9% sodium chloride, 10 mg/50 mL, (0.2 mg/mL), 50 mL Syringe, Rx only, Central Admixture Pharmacy Services, Inc., 7935 Dunbrook Road, Suite C, San Diego, CA 92126, NDC 71286-2010-2

Reason for Recall

Lack of assurance of sterility:

Recalling Firm

Central Admixture Pharmacy Services Inc — San Diego, CA

Classification

Class II — May cause temporary or medically reversible adverse health consequences.

Product Type

Drugs

Product Quantity

1,190 50 mL syringes

Distribution

Nationwide in the USA

Code Information

Lot:17-275728, Exp. 10/9/2023; 17-275791, 17-275803, Exp. 10/10/2023; 17-276244, Exp. 10/20/2023.

Status

Terminated

Voluntary / Mandated

Voluntary: Firm initiated